Senti Biosciences
SNTI

Senti Biosciences (SNTI) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$0.56
EPS estimate
−$0.90
Revenue
$0.00
Revenue estimate
$500,000.00
Reported
Aug 7, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 7, 2025−$0.90−$0.56+37.78%$0.00SEC
Q1 2025May 6, 2025−$0.56−$1.41−151.79%$0.00SEC
Q4 2024Mar 20, 2025−$3.13−$0.67+78.59%$2.8MSEC
Q3 2024Nov 14, 2024$0.00−$6.31+0.00%$0.00SEC
Q2 2024Aug 13, 2024$0.00−$2.45+0.00%$0.00SEC
Q1 2024May 9, 2024$0.00−$2.60+0.00%$0.00SEC
Q4 2023Mar 21, 2024−$4.20−$4.20+0.00%$0.00SEC
Q3 2023Nov 13, 2023−$4.42−$3.40+23.08%$338,000.00SEC
Q2 2023Aug 11, 2023−$4.77−$4.20+11.89%$937,000.00SEC
Q1 2023May 9, 2023−$4.33−$4.20+3.08%$1.3MSEC
Q4 2022Mar 22, 2023−$4.39−$4.20+4.25%$59,000.00SEC
Q3 2022Nov 10, 2022−$4.57−$3.80+16.79%$1.8M
Q2 2022Aug 15, 2022$0.00−$5.65+0.00%$1.4MSEC

Quarterly revenue

Q2 2022
$1.4M
Q3 2022
$1.8M
Q4 2022
$59,000.00
Q1 2023
$1.3M
Q2 2023
$937,000.00
Q3 2023
$338,000.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$2.8M
Q1 2025
$0.00
Q2 2025
$0.00

Frequently asked questions

  • When did Senti Biosciences (SNTI) last report earnings?

    Senti Biosciences last reported on Aug 7, 2025, covering fiscal Q2 2025.

  • Did SNTI beat earnings estimates?

    Yes. Senti Biosciences reported EPS of −$0.56 for Q2 2025 against a −$0.90 estimate — a 37.78% beat.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.